MTOR and metabolic dysfunction-associated steatotic liver disease: There is currently a lack of systematic elucidation of the relationship between mTOR and metabolic diseases, such as NAFLD; thus, this review aims to provide an update on research on NAFLD in metabolic diseases and advocates for a shift in research attention to address the crucial need for more research and development of mTOR inhibitors for application in metabolic diseases.